Osteoporosis is a long-term disease which makes your bones less dense and more fragile. If you have osteoporosis, you are more likely to fracture or break a bone if you have a mild injury or minor fall.
Some doctors, medical specialists or patients choose Zoledronic Acid (Aclasta TM) intravenous infusion as the preferred treatment for osteoporosis. Aclasta TM is a form of bisphosphonate. The infusion usually only needs to be done once a year (but can be varied by your specialists).
Aclasta TM works by slowing down bone resorption, which allows the bone- forming cells time to rebuild normal bone. This allows bone remodeling to go back to normal and protects the bones from being weakened.
To qualify for Aclasta TM Infusion for treatment of Osteoporosis, under Pharmaceutical Benefits Scheme (PBS), one need to be diagnosed with:
Osteoporosis as per criteria below:
Corticosteroid – induced osteoporosis as per criteria below:
Aclasta TM may have a particular role for people in whom an oral bisphosphonate is unsuitable or not tolerated, such as those who:
Often patients prefer a once-a-year Aclasta TM infusion to regular oral tablets over a one-year period (as one may not always remember to take the tablets).
Aclasta TM is found to be similar in efficacy to ProliaTM (Denosumab), another injectable, in treating osteoporosis. However, the increased bone density achieved by Aclasta TM infusion is often long- standing and relatively well preserved, which is different in nature to that of Prolia’s.
Prolia needs to be given almost indefinitely, every 6 months, to maintain the increased bone density. The reason for this is once Prolia injections stop, there is an increase in bone turnover and rapid bone resorption. Stopping Prolia can cause an increase in the number of fractures, often within a year of stopping.
Aclasta TM infusions is also used to treat a range of other medical conditions including symptomatic Paget’s Disease, hypercalcaemia due to cancer, bone break down due to cancer, Duchene Muscular dystrophy and multiple other conditions (as approved by your treating medical specialists).
We will review your medical condition (s), and if appropriate, arrange consent for an Aclasta TM infusion.
It will be appreciated if you can obtain from your referring doctor a copy of:
The second consultation is for the actual Aclasta TM infusion. Your doctor / nurse will insert a cannula, usually into your arm using a clean / aseptic technique.
The infusion process normally takes about 20 – 30 minutes and in general, you have to be observed for a further period of time after the infusion.
We welcome referrals from medical specialists. If you are a medical specialist and you would like to refer your patient to us for an Aclasta TM Infusion, we appreciate if you can complete the Referral Form for Aclasta Zoledronic Acid Infusion.
It will be appreciated if you can provide your patient with:
Brisbane Aclasta Infusions: Please note prior to an Aclasta infusion you require an initial consultation with one of our GP’s. Feel free to contact our team should you have any queries.
Beenleigh Marketplace, 114-118 George Street, Beenleigh QLD 4207
Cannon Hill Clinic
Shop 1 K Mart Plaza Cannon Hill, 1909 Creek Road, Cannon Hill Qld 4170
Cnr of Redland Bay & Mt Cotton Roads, Capalaba QLD 4157
The Village Coorparoo, 398 Cavendish Road, Coorparoo QLD 4151
Shop 10 and 11, Greenslopes Mall, 700 Logan Rd, Greenslopes QLD 4120
Unit 8-10, 2770 Logan Road, Underwood, QLD, 4119
West End Clinic
Suite 2, Healthcare Hub Floor 1, Montague Markets, 405 Montague Rd, West End Qld 4101
Expression of Interest